BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Globus Medical Inc (Symbol: GMED) entered into oversold territory, hitting an RSI reading of ...

Joining today's call from Globus Medical will be Dan Scavilla ... The integration of the reline fixation system with the Excelsius enabling technology suite creates a powerful synergy of trusted ...

Globus Medical reported its financial results for Q1 2025, revealing a miss on both earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.68, falling short of the ...

NEW DELHI: Globus Spirits Ltd, known for its Terai gin and Doaab single malt, is looking to expand into new categories, including beer and additional variants of single malt whisky, as part of its ...

Globus finished 2024 with a great fourth quarter ... Cortex MIS is integrated with our advanced Excelsius technology and designed for accurate screw placement using a minimally invasive robotic ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

The Globus family of brands will host a roadshow with more than 100 events across North America in February. Photo Credit: Globus family of brands The Globus family of brands is launching in ...

He had an idea to fix Reed's pain with another surgery. He planned to use a new surgical robot for the hospital, the Globus Excelsius. The machine acts as a GPS for surgical use, allowing precise ...

Reed is now able to hike again, thanks to a medical technology called Globus Excelsius. Neurosurgeon at Trinity Health Muskegon, Dr. Lynagh, describes the device as a GPS for spinal surgeries ...